At a glance
ClinicalIndex Comparison RecordN/ACompleted· 2,217 enrolled
Drug / intervention
Fractional Flow Reservedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Practical Evaluation of Fractional Flow Reserve (FFR) and Its Associated Alternate Indices During Routine Clinical Procedures
In Brief
An observational study evaluating Fractional Flow Reserve for Coronary Artery Disease and Acute Coronary Syndrome. Completed, enrolled 2,217 participants across 71 sites in 15 countries.
Detailed Summary
The purpose of this study is to understand routine use of FFR (Fractional Flow Reserve) and alternate indices in clinical practice. This study will determine the use and clinical outcome of FFR-guided PCI in patients presenting with either stable coronary artery disease, or in patients presenting with Acute Coronary Syndrome (ACS) on culprit and non-culprit lesions as well as during index and secondary procedures.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease, Acute Coronary Syndrome
CountriesAustria, Canada, Egypt, Estonia, Germany, Greece, India, Italy, Japan, Netherlands, Portugal, Saudi Arabia, Spain, United Kingdom, United States
Collaborators--
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartOct 2016
First PostedOct 2016
Primary CompletionMar 2019
TodayJul 2026
First PostedOct 17, 2016
Enrollment StartOct 12, 2016
Primary CompletionMar 22, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 9.7 years ago
Interventions
Fractional Flow Reservedevice
Measurement of physiologic parameters